VANCOUVER, BC — (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”) a Canadian clinical stage pharmaceutical development company announces it is undertaking… Read More
Ten local businesses and organizations will receive funding to commercialize new technology, grow their operations, and reach new markets VANCOUVER, BC — British Columbia has the people, ideas and resources… Read More
This investment from the Pacific Economic Development Agency of Canada will help broaden the application of Aspect’s bioprinting technology for therapeutic development, expand its global network of partners, and scale-up… Read More
VANCOUVER, BC — /PRNewswire/ — As a proud donor to M.D. Anderson Cancer Center since 2019, WAT Medical Enterprise expands its philanthropic campaign by initiating its Red Cross charity starting… Read More
Report details findings and recommendations on strengthening support system for science and research OTTAWA, ON — Canada is a global leader in research and innovation, and our world-class researchers perform… Read More
